Enhanced predictive value of post-treatment lymphocyte-based immunoinflammatory biomarkers for cancer therapy-related cardiac dysfunction in anthracycline-treated breast cancer patients.

Cardiooncology · 2026 · PMC13032571 · PMID 41723500

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Neutrophil and monocyte counts showed a slight increase, while lymphocyte counts exhibited a marked decrease in the CTRCD group relative to the non-CTRCD group in pre-treatment; however, these differences did not reach statistical significance.

also in 111,027 other papers

showed a trendno p-value reported

Similarly, pre-treatment lymphocyte-based immunoinflammatory biomarkers showed a trend of alteration between groups without significant differences.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.